Annual Total Long Term Liabilities
$3.06 M
-$54.73 M-94.71%
December 31, 2022
Summary
- As of February 10, 2025, LMNL annual total long term liabilities is $3.06 million, with the most recent change of -$54.73 million (-94.71%) on December 31, 2022.
- During the last 3 years, LMNL annual total long term liabilities has fallen by -$26.72 million (-89.74%).
Performance
LMNL Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Liabilities
$818.00 K
+$87.60 K+11.99%
June 30, 2023
Summary
- As of February 10, 2025, LMNL quarterly total long term liabilities is $818.00 thousand, with the most recent change of +$87.60 thousand (+11.99%) on June 30, 2023.
- Over the past year, LMNL quarterly long term liabilities has dropped by -$20.31 million (-96.13%).
Performance
LMNL Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
LMNL Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -94.7% | -96.1% |
| 3 y3 years | -89.7% | -97.0% |
| 5 y5 years | -96.3% | -99.2% |
LMNL Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -94.7% | at low | -98.6% | -10.7% |
| 5 y | 5-year | -95.1% | at low | -98.8% | -10.7% |
| alltime | all time | -96.8% | -87.9% | -99.4% | -96.7% |
Liminal BioSciences Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $818.00 K(+12.0%) |
| Mar 2023 | - | $730.40 K(-76.1%) |
| Dec 2022 | $3.06 M(-94.7%) | $3.06 M(-4.2%) |
| Sep 2022 | - | $3.19 M(-84.9%) |
| Jun 2022 | - | $21.13 M(-11.2%) |
| Mar 2022 | - | $23.81 M(-58.8%) |
| Dec 2021 | $57.79 M(-6.7%) | $57.79 M(-5.5%) |
| Sep 2021 | - | $61.14 M(-13.4%) |
| Jun 2021 | - | $70.58 M(+17.0%) |
| Mar 2021 | - | $60.32 M(-2.6%) |
| Dec 2020 | $61.95 M(+108.0%) | $61.95 M(+21.5%) |
| Sep 2020 | - | $50.96 M(+84.7%) |
| Jun 2020 | - | $27.60 M(+1.0%) |
| Mar 2020 | - | $27.32 M(-8.3%) |
| Dec 2019 | $29.78 M(-68.9%) | $29.78 M(-14.2%) |
| Sep 2019 | - | $34.72 M(+1.8%) |
| Jun 2019 | - | $34.10 M(-74.8%) |
| Mar 2019 | - | $135.08 M(+41.2%) |
| Dec 2018 | $95.67 M(+15.2%) | $95.67 M(-27.1%) |
| Sep 2018 | - | $131.32 M(+21.5%) |
| Jun 2018 | - | $108.05 M(+10.1%) |
| Mar 2018 | - | $98.14 M(+18.2%) |
| Dec 2017 | $83.04 M(+51.5%) | $83.04 M(+16.8%) |
| Sep 2017 | - | $71.12 M(+0.4%) |
| Jun 2017 | - | $70.87 M(+29.0%) |
| Mar 2017 | - | $54.93 M(+0.2%) |
| Dec 2016 | $54.81 M(+35.5%) | $54.81 M(+0.7%) |
| Sep 2016 | - | $54.41 M(-1.5%) |
| Jun 2016 | - | $55.22 M(-4.9%) |
| Mar 2016 | - | $58.06 M(+43.5%) |
| Dec 2015 | $40.46 M(-23.0%) | $40.46 M(-6.0%) |
| Sep 2015 | - | $43.04 M(-8.6%) |
| Jun 2015 | - | $47.11 M(-2.3%) |
| Mar 2015 | - | $48.22 M(-8.2%) |
| Dec 2014 | $52.55 M(+768.7%) | $52.55 M(-6.1%) |
| Sep 2014 | - | $55.95 M(+27.0%) |
| Jun 2014 | - | $44.05 M(+623.6%) |
| Mar 2014 | - | $6.09 M(+0.6%) |
| Dec 2013 | $6.05 M(+46.7%) | $6.05 M(+1.2%) |
| Sep 2013 | - | $5.98 M(+42.2%) |
| Jun 2013 | - | $4.21 M(+39.8%) |
| Mar 2013 | - | $3.01 M(-27.0%) |
| Dec 2012 | $4.12 M(-22.7%) | $4.12 M(+217.7%) |
| Sep 2012 | - | $1.30 M(-70.9%) |
| Jun 2012 | - | $4.46 M(+4.3%) |
| Mar 2012 | - | $4.28 M(-19.7%) |
| Dec 2011 | $5.34 M | $5.34 M(+205.9%) |
| Sep 2011 | - | $1.74 M(-66.5%) |
| Jun 2011 | - | $5.20 M(-2.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2011 | - | $5.33 M(-59.6%) |
| Dec 2010 | $13.20 M(+237.6%) | $13.20 M(+30.0%) |
| Sep 2010 | - | $10.16 M(-13.5%) |
| Jun 2010 | - | $11.75 M(-0.2%) |
| Mar 2010 | - | $11.77 M(+201.1%) |
| Dec 2009 | $3.91 M(+9.7%) | $3.91 M(+7.1%) |
| Sep 2009 | - | $3.65 M(-12.8%) |
| Jun 2009 | - | $4.19 M(+11.8%) |
| Mar 2009 | - | $3.75 M(+5.1%) |
| Dec 2008 | $3.56 M(-42.6%) | $3.56 M(-1.1%) |
| Sep 2008 | - | $3.60 M(-17.5%) |
| Jun 2008 | - | $4.37 M(-19.9%) |
| Mar 2008 | - | $5.45 M(-12.1%) |
| Dec 2007 | $6.21 M(-38.7%) | $6.21 M(-18.1%) |
| Sep 2007 | - | $7.58 M(-6.8%) |
| Jun 2007 | - | $8.14 M(-3.4%) |
| Mar 2007 | - | $8.42 M(-16.8%) |
| Dec 2006 | $10.13 M(+35.3%) | $10.13 M(+70.2%) |
| Sep 2006 | - | $5.95 M(+3.4%) |
| Jun 2006 | - | $5.76 M(-1.4%) |
| Mar 2006 | - | $5.84 M(-22.0%) |
| Dec 2005 | $7.49 M(+351.6%) | $7.49 M(+72.4%) |
| Sep 2005 | - | $4.34 M(+159.0%) |
| Jun 2005 | - | $1.68 M(+0.5%) |
| Mar 2005 | - | $1.67 M(+0.7%) |
| Dec 2004 | $1.66 M(+22.3%) | $1.66 M(+13.3%) |
| Sep 2004 | - | $1.46 M(+4.4%) |
| Jun 2004 | - | $1.40 M(+4.1%) |
| Mar 2004 | - | $1.35 M(-0.7%) |
| Dec 2003 | $1.36 M(+267.5%) | $1.36 M(+18.0%) |
| Sep 2003 | - | $1.15 M(+2.4%) |
| Jun 2003 | - | $1.12 M(+32.4%) |
| Mar 2003 | - | $847.70 K(+129.7%) |
| Dec 2002 | $369.00 K(-55.3%) | $369.00 K(+150.5%) |
| Sep 2002 | - | $147.30 K(-11.5%) |
| Jun 2002 | - | $166.50 K(+519.0%) |
| Sep 2000 | - | $26.90 K(-96.4%) |
| Jun 2000 | - | $742.50 K(-10.1%) |
| Mar 2000 | - | $826.00 K(+0.1%) |
| Dec 1999 | $825.20 K(-76.8%) | $825.20 K(-42.3%) |
| Sep 1999 | - | $1.43 M(-62.9%) |
| Jun 1999 | - | $3.86 M(-4.6%) |
| Mar 1999 | - | $4.04 M(+13.8%) |
| Dec 1998 | $3.55 M(+40.2%) | $3.55 M(+25.9%) |
| Sep 1998 | - | $2.82 M(-20.4%) |
| Jun 1998 | - | $3.55 M(+7.4%) |
| Mar 1998 | - | $3.30 M(-24.9%) |
| Dec 1997 | - | $4.40 M |
| Sep 1997 | $2.53 M | - |
FAQ
- What is Liminal BioSciences annual total long term liabilities?
- What is the all time high annual total long term liabilities for Liminal BioSciences?
- What is Liminal BioSciences annual total long term liabilities year-on-year change?
- What is Liminal BioSciences quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Liminal BioSciences?
- What is Liminal BioSciences quarterly long term liabilities year-on-year change?
What is Liminal BioSciences annual total long term liabilities?
The current annual total long term liabilities of LMNL is $3.06 M
What is the all time high annual total long term liabilities for Liminal BioSciences?
Liminal BioSciences all-time high annual total long term liabilities is $95.67 M
What is Liminal BioSciences annual total long term liabilities year-on-year change?
Over the past year, LMNL annual total long term liabilities has changed by -$54.73 M (-94.71%)
What is Liminal BioSciences quarterly total long term liabilities?
The current quarterly long term liabilities of LMNL is $818.00 K
What is the all time high quarterly long term liabilities for Liminal BioSciences?
Liminal BioSciences all-time high quarterly total long term liabilities is $135.08 M
What is Liminal BioSciences quarterly long term liabilities year-on-year change?
Over the past year, LMNL quarterly total long term liabilities has changed by -$20.31 M (-96.13%)